GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 126 - 150 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgM Patient 2 15 mild
G35446HX
6312
IgG Patient 2 15 mild
G32473MI
6271
IgM Patient 3 -180 mild
G76615YG
6196
IgM Patient 2 24 mild
G35446HX
6016
IgM Patient 3 11 mild
G12200GB
5944
IgA Patient 4 12 mild
G81315DD
5922
IgM Patient 3 4 mild
G12200GB
5741
IgM Patient 3 4 mild
G43648DB
5607
IgM Patient 2 24 mild
G25559RS
5565
IgM Patient 3 11 mild
G26295XE
5294
IgM Patient 3 4 mild
G51175PR
5287
IgM Patient 4 12 mild
G80587NA
5240
IgG Patient 3 4 mild
G68703KI
5185
IgM Patient 4 12 mild
G10133VD
5152
IgA Patient 3 -180 mild
G96865DJ
5132
IgA Patient 3 -180 mild
G49108TO
5055
IgG Patient 2 15 mild
G37036SF
5047
IgM Patient 3 4 mild
G26295XE
4981
IgG Patient 2 24 mild
G47566FL
4947
IgG Patient 2 24 mild
G93351GM
4880
IgG Patient 2 15 mild
G47566FL
4857
IgG Patient 3 11 mild
G68703KI
4801
IgG Patient 3 4 mild
G14569AR
4766
IgG Patient 2 3 mild
G15407YE
4477
IgM Patient 3 11 mild
G51175PR
4475

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024